The national law firm of Baron and Budd has reached a $177 million
settlement with GlaxoSmithKline on behalf of the states of Kentucky,
Maryland, Mississippi, New Mexico, South Carolina, Utah and West
Virginia regarding the deceptive advertising of the diabetes drug
Avandia. This result represents the largest settlement of a
pharmaceutical case ever for several of the involved states, and a much
higher settlement for each individual state than what they would
otherwise have received in a multistate settlement reached in 2012.
Baron and Budd attorneys Russell Budd, Burton LeBlanc, Laura Baughman
and S. Ann Saucer served in the litigation alongside co-counsel and each
state's Office of the Attorney General.
Russell Budd (Photo: Business Wire)
In the lawsuit, GlaxoSmithKline, the manufacturer of Avandia, was
accused of misrepresenting the safety and efficacy of the drug,
specifically stating that Avandia reduced adverse cardiac events, when
itactually increased them.
Baron and Budd worked with the office of each state's Attorney General,
including Jack Conway, the Attorney General of Kentucky; Doug Gansler,
the Attorney General of Maryland; Jim Hood, the Attorney General of
Mississippi; Gary King, the Attorney General of New Mexico; Alan Wilson,
the Attorney General of South Carolina; Sean Reyes, the Attorney General
of Utah; and Patrick Morrisey, the Attorney General of West Virginia.
"These states truly made a wise move to opt out of the nationwide
Avandia settlement and, instead, pursue independent litigation," said
Russell Budd. "We are honored to have represented them."
With more than 35 years of experience, Baron and Budd has established
itself as one of the nation's leading plaintiffs' law firms,
spearheading meaningful litigation on behalf of consumers. Over the past
year, the firm has taken a leadership role in negotiating settlements on
behalf of the states of West Virginia, Mississippi and Hawaii regarding
the deceptive marketing practices of credit card payment protection
plans. To date, these settlements total more than $21 million. The firm
has helped negotiate sweeping national settlements regarding excessive
bank overdraft fees, including a $410 million settlement with Bank of
America and a $110 million settlement with JPMorgan Chase. Baron and
Budd shareholder Burton LeBlanc currently serves on the Plaintiff's
Steering Committee in litigation surrounding GranuFlo, a product used in
dialysis and administered at Fresenius Medical Clinics across the
About Baron & Budd, P.C.
With a history of over 35 years "Protecting What's Right" for
individuals, communities, and governmental entities, Baron and Budd is a
well-established law firm devoted to making a positive difference. With
offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd
is able to take on complicated and expensive cases within the realms of
dangerous drugs and medical devices, asbestos-related illnesses,
consumer fraud, water contamination, the Gulf oil spill and fraudulent
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140613005934/en/
[ Back To NFVZone's Homepage ]